Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017614
Filing Date
2025-06-17
Accepted
2025-06-17 20:00:13
Documents
1
Period of Report
2025-06-15

Document Format Files

Seq Description Document Type Size
1 form4-06172025_080609.html 4  
1 form4-06172025_080609.xml 4 6108
  Complete submission text file 0001415889-25-017614.txt   7626
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALA PHARMACEUTICALS, INC. 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address
Farid Marjan (Reporting) CIK: 0001952098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 251054808